Children and COVID-19: Microbiological and immunological insights.
Daniele Antonio PizzutoMichela SaliDavide PataCristina De RoseMaurizio SanguinettiPiero ValentiniGiovanni DeloguPublished in: Pediatric pulmonology (2020)
Since its first description in China, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide being declared a pandemic by the World Health Organization. More than 10.3 million people have been infected and more than 506 000 people died. However, SARS-CoV-2 had a lower impact on the pediatric population. Only about 1% to 2% of infected people are children and few deaths under the age of 14 are described so far. In this article, we discuss microbiological and immunological characteristics of SARS-CoV-2 infection in children highlighting the main differences from adult SARS-CoV-2 infection.